Skip to main content
SpringerLink
Log in

Viral Diseases and Exanthems of the Skin

  • Chapter
  • First Online:
Book cover Therapy in Pediatric Dermatology

  • 1479 Accesses

Abstract

Viral diseases are common in children and may manifest in the skin as exanthems or specific lesions such as vesicles, bullae, erosions, ulcers, papules, plaques, and tumors. These illnesses range from serious and life-threatening in the case of smallpox to innocuous and cosmetically concerning as in flat warts. The incidence of certain viral diseases like rubella, measles, and varicella has been dramatically decreased in the developing world through immunization programs. For others, like Herpes simplex virus 1 and 2 and herpes zoster, we have targeted antiviral therapies. Human papilloma virus-induced warts and poxvirus-induced molluscum lesions are extremely common pediatric problems without specific antiviral therapies, and thus numerous possible, but often ineffective, treatments exist. There are viral-associated childhood exanthems with distinctive morphologies in which we can only offer observation, symptomatic treatment, and supportive care. These include unilateral laterothoracic exanthem, Gianotti-Crosti syndrome, erythema infectiosum, papular purpuric gloves and socks syndrome, roseola, Epstein Barr Virus-induced mononucleosis, and many of the enteroviral illnesses. Finally, we have progress to make in the management of rarer cutaneous viruses such as orf and cowpox. The management of all of these viruses will be discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Faden H. Management of primary herpetic gingivostomatitis in young children. Pediatr Emerg Care. 2006;22:268–9.

    Article  PubMed  Google Scholar 

  2. Hopper SM, McCarthy M, Tancharoen C, Lee KJ, Davidson A, Babl FE. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014;63:292–9.

    Article  PubMed  Google Scholar 

  3. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double-blind placebo-controlled study. BMJ. 1997;314:1800–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Nasser M, Fedorowicz Z, Khoshnevisan MH, Shahiri Tabarestani M. Acyclovir for treating primary herpetic gingivostomatitis. Cochrane Database Syst Rev. 2008:8;4: CD006700.

    Google Scholar 

  5. Meyers JD, Wade JC, Mitchell CD, Saral R, Lietman PS, Durack DT, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med. 1982;73:229–35.

    Article  CAS  PubMed  Google Scholar 

  6. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982;96:265–9.

    Article  CAS  PubMed  Google Scholar 

  7. Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-controlled trial. Am J Med. 1992;92:30S–5.

    Article  CAS  PubMed  Google Scholar 

  8. Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001;45:222–30.

    Article  CAS  PubMed  Google Scholar 

  9. Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled multicenter clinical trials. Antimicrob Agents Chemother. 2002;46:2238–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical penciclovir collaborative study group. JAMA. 1997;277:1374–9.

    Article  CAS  PubMed  Google Scholar 

  11. Nasser M, Fedorowicz Z, Khoshnevisan MH, Shahiri Tabarestani M. Acyclovir for treating primary herpetic gingivostomatitis. Cochrane Database Syst Rev. 2008; CD006700.

    Google Scholar 

  12. Spruance SL, Stewart JCB, Rowe NH, McKeough MB, Wenerstrom G, Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis. 1990;161:185–90.

    Article  CAS  PubMed  Google Scholar 

  13. Spruance SL, Bodsworth N, Resnick H, Conant M, Oeuvray C, Gao J, et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol. 2006;55:47–53.

    Article  PubMed  Google Scholar 

  14. Spruance SL, Jones TM, Blatter MM, Vargas-Cortez M, Barber J, Hill J, et al. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled multicenter studies. Antimicrob Agents Chemother. 2003;47:1072–80.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-controlled trial. Am J Med. 1992;92:30S–5.

    Article  CAS  PubMed  Google Scholar 

  16. Meyers JD, Wade JC, Mitchell CD, Saral R, Lietman PS, Durack DT, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med. 1982;73:229–35.

    Article  CAS  PubMed  Google Scholar 

  17. Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982;96:265–9.

    Article  CAS  PubMed  Google Scholar 

  18. Baker D, Eisen D. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis. 2003;71:239–42.

    PubMed  Google Scholar 

  19. Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind placebo-controlled trial. Ann Intern Med. 1993;118:268–72.

    Article  CAS  PubMed  Google Scholar 

  20. Rooney JF, Bryson Y, Mannix ML, Dillon M, Wohlenberg CR, Banks S, et al. Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet. 1991;338:1419–22.

    Article  CAS  PubMed  Google Scholar 

  21. American Academy of Pediatrics. Herpes simplex. In: Pickering LK, editor. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p. 398–408.

    Google Scholar 

  22. Centers for Disease Control and Prevention 2010 Sexually Transmitted Diseases Treatment Guidelines. Available at: http://www.cdc.gov/std/treatment/2010/genital-ulcers.htm#a2. Accessed 20 Dec 2014.

  23. Metz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, Redfield DC, et al. Double-blind placebo controlled trial of oral acyclovir in first episode genital herpes simplex virus infection. JAMA. 1984;252:1147–51.

    Article  Google Scholar 

  24. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis. 1997;24:481–6.

    Article  CAS  PubMed  Google Scholar 

  25. Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med. 1997;157:343–9.

    Article  CAS  PubMed  Google Scholar 

  26. Aoki FY, Tyring S, Diaz-Mitoma F, Gross G, Gao J, Hamed K. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2006;42:8–13.

    Article  CAS  PubMed  Google Scholar 

  27. Reichman RC, Badger GJ, Mertz GJ, Corey L, Richman DD, Connor JD, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA. 1984;251:2103–7.

    Article  CAS  PubMed  Google Scholar 

  28. Tyring SK, Douglas JM, Corey LC, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol. 1998;134:185–91.

    Article  CAS  PubMed  Google Scholar 

  29. Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis. 2002;34:944–8.

    Article  CAS  PubMed  Google Scholar 

  30. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11–20.

    Article  CAS  PubMed  Google Scholar 

  31. Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190:1374–81.

    Article  CAS  PubMed  Google Scholar 

  32. Mattison HR, Reichman RC, Benedetti J, Bolgiano D, Davis LG, Bailey-Farchione A, et al. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med. 1988;85:20–5.

    Article  CAS  PubMed  Google Scholar 

  33. Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-controlled trial. Am J Med. 1992;92:30S–5.

    Article  CAS  PubMed  Google Scholar 

  34. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100–6.

    Article  CAS  PubMed  Google Scholar 

  35. Hsiao CH, Yeung L, Yeh LK, Koa LY, Tan HY, Wang NK, et al. Pediatric herpes simplex virus keratitis. Cornea. 2009;28:249–53.

    Article  PubMed  Google Scholar 

  36. Schwartz GS, Holland EJ. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmology. 2000;107:278–82.

    Article  CAS  PubMed  Google Scholar 

  37. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2010;12, CD002898.

    Google Scholar 

  38. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1883–95.

    Article  CAS  PubMed  Google Scholar 

  39. Rao SN. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. Am J Ophthalmol. 2006;141:771–2.

    Article  CAS  PubMed  Google Scholar 

  40. Frisch S, Siegfried EC. The clinical spectrum and therapeutic challenge of eczema herpeticum. Pediatr Dermatol. 2011;28:46–52.

    Article  PubMed  Google Scholar 

  41. Niimura M, Nishikawa T. Treatment of eczema herpeticum with oral acyclovir. Am J Med. 1988;85:49–52.

    Article  CAS  PubMed  Google Scholar 

  42. Luca NJ, Lara-Corrales I, Pope E. Eczema herpeticum in children: clinical features and factors predictive of hospitalization. J Pediatr. 2012;161:671–5.

    Article  PubMed  Google Scholar 

  43. Aronson PL, Yan AC, Mittal MK, Mohamad Z, Shah SS. Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum. Pediatrics. 2011;128:1161–7.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Aronson PL, Yan AC, Mohamad Z, Mittal MK, Shah SS. Empiric antibiotics and outcomes of children hospitalized with eczema herpeticum. Pediatr Dermatol. 2013;30:207–14.

    Article  PubMed  Google Scholar 

  45. Aronson PL, Shah SS, Mohamad Z, Yan AC. Topical corticosteroids and hospital length of stay in children with eczema herpeticum. Pediatr Dermatol. 2013;30:215–21.

    Article  PubMed  Google Scholar 

  46. Rubright JH, Shafritz AB. The herpetic whitlow. J Hand Surg Am. 2011;36:340–2.

    Article  PubMed  Google Scholar 

  47. Szinnai G, Schaad UB, Heininger U. Multiple herpetic whitlow lesions in a 4-year-old girl: case report and review of the literature. Eur J Pediatr. 2001;160:528–33.

    Article  CAS  PubMed  Google Scholar 

  48. American Academy of Pediatrics. Herpes simplex. In: Pickering LK, editor. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p. 398–408.

    Google Scholar 

  49. National Collegiate Athletic Association: Wrestling 2013–14 and 2014–15 Rules and Interpretations. Available at: http://www.ncaapublications.com/productdownloads/WR15.pdf. Accessed 20 Dec 2014.

  50. National Federation of State High School Associations Medical Release Form for Wrestler to Participated with Skin Lesion(s). Available at: http://www.nfhs.org/media/882323/wr_skin_lesion_form-clean.pdf. Accessed 20 Dec 2014.

  51. Anderson BJ. Valacyclovir to expedite the clearance of recurrence herpes gladiatorum. Clin J Sport Med. 2005;15:364–6.

    Article  CAS  PubMed  Google Scholar 

  52. Anderson BJ. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers. Clin J Sport Wed. 1999;9:86–90.

    Article  CAS  Google Scholar 

  53. Marin M, Güris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–40.

    PubMed  Google Scholar 

  54. Klassen TP, Belseck EM, Wiebe N, Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev. 2005; CD002980.

    Google Scholar 

  55. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, editor. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p. 774–88.

    Google Scholar 

  56. Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, et al. Varicella among adults: data from an active surveillance project, 1995–2005. J Infect Dis. 2008;197 Suppl 2:S94–100.

    Article  PubMed  Google Scholar 

  57. Kimberlin DW, Jacobs RF, Weller D, van der Walt JS, Heitman CK, Man CY, et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis. 2010;50:221–8.

    Article  PubMed  CAS  Google Scholar 

  58. Hill G, Chauvenet AR, Lovato J, McLean TW. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia. Pediatrics. 2005;116:e525–9.

    Article  PubMed  Google Scholar 

  59. Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis. 1988;157:309–13.

    Article  CAS  PubMed  Google Scholar 

  60. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus in an immunosuppressed child. J Infect Dis. 2003;188:954–9.

    Article  PubMed  Google Scholar 

  61. Macartney K, Heywood A, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database Syst Rev. 2014;6, CD001833.

    Google Scholar 

  62. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of VariZIG – United States, 2013. MMWR Morb Mortal Wkly Rep. 2013;62:574–6.

    Google Scholar 

  63. Chen SH, Liang DC. Intravenous immunoglobulin prophylaxis in children with acute leukemia following exposure to varicella. Pediatr Hematol Oncol. 1992;9:347–51.

    Article  CAS  PubMed  Google Scholar 

  64. Kakourou T, Theodoridou M, Mostrou G, Syriopoulou V, Pagadogeorgaki H, Constantopoulos A. Herpes zoster in children. J Am Acad Dermatol. 1998;39:207–10.

    Article  CAS  PubMed  Google Scholar 

  65. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996;22:341–7.

    Article  CAS  PubMed  Google Scholar 

  66. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr. 1996;128:353–6.

    Article  CAS  PubMed  Google Scholar 

  67. Leung J, Harpax R, Baughman AL, Heath K, Loparev V, Vazquez M, et al. Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis. 2010;51:23–32.

    Article  CAS  PubMed  Google Scholar 

  68. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993–2000.

    Article  CAS  PubMed  Google Scholar 

  69. Roy M, Bailey B, Amre DK, Girodias JB, Bussières JF, Gaudreault P. Dexamethasone for the treatment of sore throat in children with suspected infectious mononucleosis: a randomized, double-blind, placebo-controlled, clinical trial. Arch Pediatr Adolesc Med. 2004;158:250–4.

    Article  PubMed  Google Scholar 

  70. Di Lernia V, Mansouri Y. Epstein-Barr virus and skin manifestations in childhood. Int J Dermatol. 2013;52:1177–84.

    Article  PubMed  Google Scholar 

  71. Silverberg JI, Silverberg NB. The US prevalence of common warts in childhood: a population-based study. J Invest Dermatol. 2013;133:2788–90.

    Article  CAS  PubMed  Google Scholar 

  72. Daniel BS, Murrell DF. Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine. JAMA Dermatol. 2013;149:370–2.

    Article  PubMed  Google Scholar 

  73. Bruggink SC, Eekhof JA, Egberts PF, van Blijswijk SC, Assendelft WJ, Gussekloo. Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study. J Ann Fam Med. 2013;11:437–41.

    Article  Google Scholar 

  74. de Haen M, Spigt MG, van Uden CJ, van Neer P, Feron FJ, Knottnerus A. Efficacy of duct tape vs placebo in the treatment of verruca vulgaris (warts) in primary school children. Arch Pediatr Adolesc Med. 2006;160:1121–5.

    Article  PubMed  Google Scholar 

  75. Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011;165:233–46.

    Article  CAS  PubMed  Google Scholar 

  76. Ahn CS, Huang WW. Imiquimod in the treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2014;15:387–99.

    Article  PubMed  Google Scholar 

  77. Gladsjo JA, Alió Sáenz AB, Bergman J, Kricorian G, Cunningham BB. % 5-Fluorouracil cream for treatment of verruca vulgaris in children. Pediatr Dermatol. 2009;26:279–85.

    Article  PubMed  Google Scholar 

  78. Grillo E, Boixeda P, Ballester A, Miguel-Morrondo A, Truchuelo T, Jaén P. Pulsed dye laser treatment for facial flat warts. Dermatol Ther. 2014;27:31–5.

    Article  CAS  PubMed  Google Scholar 

  79. Kang HS, Lee MW, Paek JO, Yu HJ, Kim JS. Comparison of cure rates and durations of treatment with diphenylcyclopropenone immunotherapy for warts in children/adolescents and adults. Int J Dermatol. 2014;53:1293–8.

    Article  CAS  PubMed  Google Scholar 

  80. Kimura U, Takeuchi K, Kinoshita A, Takamori K, Suga Y. Long-pulsed 1064-nm neodymium:yttrium-aluminum-garnet laser treatment for refractory warts on hands and feet. J Dermatol. 2014;41:252–7.

    Article  CAS  PubMed  Google Scholar 

  81. Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. 2008;25:189–92.

    Article  PubMed  Google Scholar 

  82. Micali G, Nasca MR, Tedeschi A, Dall’Oglio F, Pulvirenti N. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children. Pediatr Dermatol. 2000;17:315–8.

    Article  CAS  PubMed  Google Scholar 

  83. Padilla Espana L, del Boz J, Fernandez Morano J, Arenas Villafranca J, de Troya Martin M. Topical cidofovir for plantar warts. Dermatol Ther. 2014;27:89–93.

    Article  PubMed  Google Scholar 

  84. Pandey S, Wilmer EN, Morrell DS. Examining the efficacy and safety of squaric acid therapy for treatment of recalcitrant warts in children. Pediatr Dermatol. 2015;32:85–90.

    Article  PubMed  Google Scholar 

  85. Silverberg JI, Silverberg NB. Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris. J Drugs Dermatol. 2012;11:1228–30.

    CAS  PubMed  Google Scholar 

  86. Adalatkhah H, Khalilollahi H, Amini N, Sadeghi-Bazargani H. Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common warts: a randomized clinical trial. Dermatol Online J. 2007;13:4.

    CAS  PubMed  Google Scholar 

  87. Gupta M, Bayliss SJ, Berk DR. Topical cidofovir for refractory verrucae in children. Pediatr Dermatol. 2013;30:131–4.

    Article  PubMed  Google Scholar 

  88. Thornsberry L, English JC. Evidence-based treatment and prevention of external genital warts in female pediatric and adolescent patients. J Pediatr Adolesc Gynecol. 2012;25:150–4.

    Article  CAS  PubMed  Google Scholar 

  89. American Academy of Pediatrics. Summaries of infectious diseases. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red book: 2012 report of the Committee on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics; 2012. p. 524–30.

    Google Scholar 

  90. Gilson RJ, Ross J, Maw R, Rowen D, Sonnex C, Lacey CJ. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts. Sex Transm Infect. 2009;85:514–9.

    Article  CAS  PubMed  Google Scholar 

  91. Jensen SL. Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminate. Lancet. 1985;23:1146–8.

    Article  Google Scholar 

  92. Ali H, Guy RJ, Wand H, Read TR, Regan DG, Grulich AE, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis. 2013;208:385–93.

    Article  CAS  PubMed  Google Scholar 

  94. Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, et al. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. JAMA. 2014;311:597–603.

    Article  CAS  PubMed  Google Scholar 

  95. Forcier M, Musacchio N. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatol Ther. 2010;23:458–76.

    Article  PubMed  Google Scholar 

  96. Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts. Sex Transm Dis. 2011;38:216–8.

    Article  CAS  PubMed  Google Scholar 

  97. Moresi JM, Herbert CR, Cohen BA. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream. Pediatr Dermatol. 2001;18:448–50.

    Article  CAS  PubMed  Google Scholar 

  98. Baker DA, Ferris DG, Martens MG, Fife KH, Tyring SK, Edwards L, et al. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies. Infect Dis Obstet Gynecol. 2011;2011:806105.

    PubMed  PubMed Central  Google Scholar 

  99. Batista CS, Atallah AN, Saconato H, da Silva EM. 5-FU for genital warts in non-immunocompromised individuals Cochrane Database Syst Rev. 2010;4; CD006562.

    Google Scholar 

  100. Loureiro WR, Cação FM, Belda Jr W, Fagundes LJ, Romiti R. Treatment of genital warts in men with potassium hydroxide. Br J Dermatol. 2008;158:180–1.

    CAS  PubMed  Google Scholar 

  101. Varma S, Lathrop E, Haddad LB. Pediatric condyloma acuminata. J Pediatr Adolesc Gynecol. 2013;26:e121–2.

    Article  PubMed  Google Scholar 

  102. Dall’ Oglio F, Nasca MR, D’Agata O, Micali G. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenital warts. Sex Transm Infect. 2002;78:309–10.

    Article  PubMed  Google Scholar 

  103. Franco I. Oral cimetidine for the management of genital and perigenital warts in children. J Urol. 2000;164:1074–5.

    Article  CAS  PubMed  Google Scholar 

  104. Rogers CJ, Gibney MD, Siegfried EC, Harrison BR, Glaser DA. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41:123–7.

    Article  CAS  PubMed  Google Scholar 

  105. Chen M, Xie J, Han. Photodynamic therapy of condyloma acuminatum in a child. Pediatr Dermatol. 2010;27:542–4.

    Article  PubMed  Google Scholar 

  106. Tatti S, Stockfleth E, Beutner KR, Tawfik H, Elsasser U, Weyrauch P, et al. Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol. 2010;162:176–84.

    Article  CAS  PubMed  Google Scholar 

  107. Snoeck R, Bossens M, Parent D, Delaere B, Degreef H, Van Ranst M, et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis. 2001;33:597–602.

    Article  CAS  PubMed  Google Scholar 

  108. Sri JC, Dubina MI, Kao GF, Rady PL, Tyring SK, Gaspari AA. Generalized verrucosis: a review of the associated diseases, evaluation, and treatments. J Am Acad Dermatol. 2012;66:292–311.

    Article  PubMed  Google Scholar 

  109. Darwich E, Darwich L, Cañadas MP, Klaustermeier J, Ercilla G, Alsina-Gibert M, et al. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir. J Am Acad Dermatol. 2011;65:e43–5.

    Article  PubMed  Google Scholar 

  110. Lee KC, Risser J, Bercovitch L. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients? Arch Dermatol. 2010;146:903–5.

    Article  PubMed  Google Scholar 

  111. Fernandez KH, Rady P, Tyring S, Stone MS. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis. Pediatr Dermatol. 2014;31:400–2.

    Article  PubMed  Google Scholar 

  112. Moore RL, de Schaetzen V, Joseph M, Lee IA, Miller-Monthrope Y, Phelps BR, Lekalake SS, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. Arch Dermatol. 2012;148:128–30.

    Article  CAS  PubMed  Google Scholar 

  113. Micali G, Nasca MR, Dall’Oglio F, Musumeci ML. Cimetidine therapy for epidermodysplasia verruciformis. J Am Acad Dermatol. 2003;48(2 Suppl):S9–10.

    Article  PubMed  Google Scholar 

  114. Fang F, Zhao L, Jiang MJ, Wang Y, Wang QQ. Epidermodysplasia verruciformis with severe hands and feet deformity successfully treated by surgical excision. Br J Dermatol. 2006;155:218.

    Article  CAS  PubMed  Google Scholar 

  115. Gubinelli E, Posteraro P, Cocuroccia B, Girolomoni G. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. J Dermatolog Treat. 2003;14:184–8.

    Article  CAS  PubMed  Google Scholar 

  116. Hoffner MV, Camacho FM. Surgical treatment of epidermodysplasia verruciformis. Dermatol Surg. 2010;36:363–7.

    Article  CAS  PubMed  Google Scholar 

  117. Karrer S, Szeimies RM, Abels C, Wlotzke U, Stolz W, Landthaler M. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1999;140:935–8.

    Article  CAS  PubMed  Google Scholar 

  118. Rallis E, Papatheodorou G, Bimpakis E, Butanska D, Menounos P, Papadakis P. Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol. 2008;22:523–5.

    Article  CAS  PubMed  Google Scholar 

  119. Zampetti A, Giurdanella F, Manco S, Linder D, Gnarra M, Guerriero G, et al. Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment. Dermatol Surg. 2013;39:974–80.

    Article  CAS  PubMed  Google Scholar 

  120. Jacobelli S, Laude H, Carlotti A, Rozenberg F, Deleuze J, Morini JP, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol. 2011;147:590–6.

    Article  PubMed  Google Scholar 

  121. Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012;129:e1072–5.

    Article  PubMed  Google Scholar 

  122. Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infect Dis. 2015;15:190–5.

    Article  PubMed  Google Scholar 

  123. van der Wouden JC, van der Sande R, van Suijlekom-Smit LW, Berger M, Butler CC, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2009;4; CD004767. doi:10.1002/14651858.CD004767.pub3.

  124. Butala N, Siegfried E, Weissler A. Molluscum BOTE sign: a predictor of imminent resolution. Pediatrics. 2013;131:e1650–3.

    Article  PubMed  Google Scholar 

  125. Al-Mutairi N, Al-Doukhi A, Al-Farag S, Al-Haddad A. Comparative study on the efficacy, safety and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children. Pediatr Dermatol. 2010;27:388–94.

    Article  PubMed  Google Scholar 

  126. Scheinfeld N. Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapalene. Dermatol Online J. 2007. Available at: http://escholarship.org/uc/item/87v1z7ht#. Accessed 12 Dec 2015.

  127. Katz KA. Dermatologists, imiquimod, and treatment of molluscum contagiosum in children: righting wrongs. JAMA Dermatol. 2015;151:125–6.

    Article  PubMed  Google Scholar 

  128. Katz KA. Imiquimod is not an effective drug for molluscum contagiosum. Lancet Infect Dis. 2014;14:372–3.

    Article  PubMed  Google Scholar 

  129. Bard S, Shiman MI, Bellman B, Connelly EA. Treatment of facial molluscum contagiosum with tricholoroacetic acid. Pediatr Dermatol. 2009;26:425–6.

    Article  PubMed  Google Scholar 

  130. Binder B, Weger W, Komericki P, Kopera D. Treatment of molluscum contagiosum with a pulsed dye laser: pilot study with 19 children. J Dtsch Dermatol Ges. 2008;6:121–5.

    Article  PubMed  Google Scholar 

  131. Dohil M, Prendiville JS. Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients. Pediatr Dermatol. 1996;13:310–2.

    Article  CAS  PubMed  Google Scholar 

  132. Enns LL, Evans MS. Intralesional immunotherapy with candida antigen for the treatment of molluscum contagiosum in children. Pediatr Dermatol. 2011;28:254–8.

    Article  PubMed  Google Scholar 

  133. Kang SH, Lee D, Hoon Park J, Cho SH, Lee SS, Park SW. Treatment of molluscum contagiosum with topical diphencyprone therapy. Acta Derm Venereol. 2005;85:529–30.

    CAS  PubMed  Google Scholar 

  134. Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatol Treat. 2005;16:336–40.

    Article  CAS  Google Scholar 

  135. Lindau MS, Munar MY. Use of duct tape occlusion in the treatment of recurrent molluscum contagiosum. Pediatr Dermatol. 2004;21:609.

    Article  PubMed  Google Scholar 

  136. Short KA, Fuller LC, Higgins EA. Double-blind, randomized placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Pediatr Dermatol. 2006;23:279–81.

    Article  PubMed  Google Scholar 

  137. Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol. 2014;31:440–9.

    Article  PubMed  Google Scholar 

  138. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503–7.

    Article  CAS  PubMed  Google Scholar 

  139. Martín-García RF, García ME, Rosado A. Modified curettage technique for molluscum contagiosum. Pediatr Dermatol. 2007;24:192–4.

    Article  PubMed  Google Scholar 

  140. Toro JR, Wood LV, Patel NK, Turner ML. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol. 2000;136:983–5.

    CAS  PubMed  Google Scholar 

  141. American Academy of Pediatrics. Summaries of infectious diseases. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red book: 2012 report of the Committee on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics; 2012. p. 511–3.

    Google Scholar 

  142. Baxby D, Bennett M, Getty B. Human cowpox 1969–93: a review based on 54 cases. Br J Dermatol. 1994;131:598–607.

    Article  CAS  PubMed  Google Scholar 

  143. Pahlitzsch R, Hammarin AL, Widell A. A case of facial cellulitis and necrotizing lymphadenitis due to cowpox virus infection. Clin Infect Dis. 2006;43:737–42.

    Article  PubMed  Google Scholar 

  144. Elsendoorn A, Agius G, Le Moal G, Aajaji F, Favier AL, Wierzbicka-Hainault E, et al. Severe ear chondritis due to cowpox virus transmitted by a pet rat. J Infect. 2011;63:391–3.

    Article  PubMed  Google Scholar 

  145. Schupp P, Pfeffer M, Meyer H, Burck G, Kölmel K, Neumann C. Cowpox virus in a 12-year-old boy: rapid identification by an orthopoxvirus-specific polymerase chain reaction. Br J Dermatol. 2001;145:146–50.

    Article  CAS  PubMed  Google Scholar 

  146. Vogel S, Sárdy M, Glos K, Korting HC, Ruzicka T, Wollenberg A. The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats. Acta Derm Venereol. 2012;92:126–31.

    Article  PubMed  Google Scholar 

  147. Blackford S, Roberts DL, Thomas PD. Cowpox infection causing a generalized eruption in a patient with atopic dermatitis. Br J Dermatol. 1993;129:628–9.

    Article  CAS  PubMed  Google Scholar 

  148. Graef S, Kurth A, Auw-Haedrich C, Plange N, Kern WV, Nitsche A, et al. Clinicopathological findings in persistent corneal cowpox infection. JAMA Ophthalmol. 2013;131:1089–91.

    Article  PubMed  Google Scholar 

  149. Al-Salam S, Nowotny N, Sohail MR, Kolodziejek J, Berger TG. Ecthyma contagiosum (orf) – report of a human case from the United Arab Emirates and review of the literature. J Cutan Pathol. 2008;35:603–7.

    Article  PubMed  Google Scholar 

  150. Ara M, Zaballos P, Sánchez M, Querol I, Zubiri ML, Simal E, et al. Giant and recurrent orf virus infection in a renal transplant recipient treated with imiquimod. J Am Acad Dermatol. 2008;58(2 Suppl):S39–40.

    Article  PubMed  Google Scholar 

  151. Degraeve C, De Coninck A, Senneseael J, Roseeuw D. Recurrent contagious ecthyma (Orf) in an immunocompromised host successfully treated with cryotherapy. Dermatology. 1999;198:162–3.

    Article  CAS  PubMed  Google Scholar 

  152. Erbağci Z, Erbağci I, Tuncel A. Rapid improvement of human orf (ecthyma contagiosum) with topical imiquimod cream: report of four complicated cases. J Dermatolog Treat. 2005;16:353–6.

    Article  PubMed  CAS  Google Scholar 

  153. Geerinck K, Lukito G, Snoeck R, De Vos R, De Clercq E, Vanrenterghem Y, et al. A case of human orf in an immunocompromised patient treated successfully with cidofovir cream. J Med Virol. 2001;64:543–9.

    Article  CAS  PubMed  Google Scholar 

  154. Lederman ER, Austin C, Trevino I, Reynolds MG, Swanson H, Cherry B, et al. Orf virus infection in children: clinical characteristics, transmission, diagnostic methods, and future therapeutics. Pediatr Infect Dis J. 2007;26:740–4.

    Article  PubMed  Google Scholar 

  155. Guharoy R, Panzik R, Noviasky JA, Krenzelok EP, Blair DC. Smallpox: clinical features, prevention, and management. Ann Pharmacother. 2004;38:440–7.

    Article  PubMed  Google Scholar 

  156. Patt HA, Feigin RD. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective. Pediatrics. 2002;109:685–92.

    Article  PubMed  Google Scholar 

  157. Boyd DA, Sperling LC, Norton SA. Eczema herpeticum and clinical criteria for investigating smallpox. Emerg Infect Dis. 2009;15:1102–4.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Keckler MS, Reynolds MG, Damon IK, Karem KL. The effects of postexposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data. Vaccine. 2013;31:5192–201.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccine. Clin Infect Dis. 2008;46:1555–61.

    Article  PubMed  Google Scholar 

  160. Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol. 2010;39 Suppl 1:i48–55.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps, and rubella in children. Cochrane Database Syst Rev [Internet]. 2012. Accessed 8 Jul 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22336803.

  162. Young MK, Nimmo GR, Cripps AW, Jones MA. Post-exposure passive immunization for preventing measles. Cochrane Database Syst Rev [Internet]. 2014. Accessed 8 Jul 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=Post-exposure+passive+immunization+for+preventing+measles.

  163. Pal G. Effects of ribavirin on measles. J Indian Med Assoc. 2011;109:666–7.

    PubMed  Google Scholar 

  164. Roy Moulik N, Kumar A, Jain A, Jain P. Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak. Pediatr Blood Cancer. 2013;60:E122–4.

    Article  PubMed  CAS  Google Scholar 

  165. Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine. 2000;18:3106–12.

    Article  CAS  PubMed  Google Scholar 

  166. Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC). Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1–12.

    PubMed  Google Scholar 

  167. Macé M, Cointe D, Six C, Levy-Bruhl D, Parent du Châtelet I, Ingrand D, et al. Diagnostic value of reverse transcription PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol. 2004;42:4818–20.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Krause I, Wu R, Sherer Y, Patanik M, Peter JB, Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med. 2002;12:133–9.

    Article  CAS  PubMed  Google Scholar 

  169. Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. J Infect Dis. 2015;211:898–905.

    Article  PubMed  Google Scholar 

  170. Bonvicini F, Bua G, Manaresi E, Gallinella G. Antiviral effect of cidofovir on parvovirus B19 replication. Antiviral Res. 2015;113:11–8.

    Article  CAS  PubMed  Google Scholar 

  171. Lallement A, Zandotti C, Brouqui P. Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report. J Med Case Rep. 2015;9:1.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, et al. A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature. Int J Clin Exp Pathol. 2014;7:2624–35.

    PubMed  PubMed Central  Google Scholar 

  173. Drwiła R, Rubiś P, Kapelak B, Rudnicka-Sosin L, Pankuweit S, Gackowski A. Complete recovery of a patient with cardiogenic shock due to parvovirus B19 fulminant myocarditis after treatment with extracorporeal membrane oxygenation and intravenous immunoglobulin. Pol Arch Med Wewn. 2015;125:199–201.

    PubMed  Google Scholar 

  174. Hsu S, Chen Y, Huang Y, Yeh T, Chen W, Ho E, et al. Prenatal diagnosis and perinatal management of maternal-fetal congenital parvovirus B19 infection. Taiwan J Obstet Gynecol. 2007;46:417–22.

    Article  PubMed  Google Scholar 

  175. Maple P, Hedman L, Dhanilall P, Kantola K, Nurmi V, Soderlund-Venermo M, et al. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. J Clin Microbiol. 2015;52:947–56.

    Article  CAS  Google Scholar 

  176. Ishikawa A, Yoto Y, Asakura H, Tsutsumi H. Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy. J Med Virol. 2015;87:683–5.

    Article  CAS  PubMed  Google Scholar 

  177. Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant. 2002;29:595–8.

    Article  CAS  PubMed  Google Scholar 

  178. Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:309–17.

    Article  CAS  PubMed  Google Scholar 

  179. Bonnafous P, Bogaert S, Godet AN, Agut H. HDP-CDV as an alternative for treatment of human herpesvirus-6 infection. J Clin Virol. 2013;56:175–6.

    Article  PubMed  Google Scholar 

  180. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 in the immunocompetent. J Clin Virol. 2005;32:183–93.

    Article  CAS  PubMed  Google Scholar 

  181. Yoshikawa T, Akimoto S, Nishimura N, Ozaki T, Ihira M, Ohashi M, et al. Evaluation of active human herpesvirus 6 infection by reverse transcription-PCR. J Med Virol. 2003;70:267–72.

    Article  CAS  PubMed  Google Scholar 

  182. Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. J Am Acad Dermatol. 2006;54:136–45.

    Article  PubMed  Google Scholar 

  183. Zawar V, Chuh A. Efficacy of ribavirin in a case of long lasting and disabling Gianotti-Crosti syndrome. J Dermatol Case Rep. 2008;2:63–6.

    Article  PubMed  PubMed Central  Google Scholar 

  184. Boeck K, Mempel M, Schmidt T, Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis. 1998;62:271–4.

    CAS  PubMed  Google Scholar 

  185. Dauendorffer JN, Dupuy A. Gianotti-Crosti syndrome associated with herpes simplex virus type 1 gingivostomatitis. J Am Acad Dermatol. 2011;64:450–1.

    Article  PubMed  Google Scholar 

  186. Kennedy CE, Azfar RS, Honig PJ. Lyme disease as a cause of acropapular dermatitis of childhood. Pediatr Dermatol. 2009;26:635–6.

    Article  PubMed  Google Scholar 

  187. Lowe L, Hebert AA, Duvic M. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. J Am Acad Dermatol. 1989;20:336–8.

    Article  CAS  PubMed  Google Scholar 

  188. May J, Pollack R. Gianotti-Crosti syndrome associated with type A influenza. Pediatr Dermatol. 2011;28:733–4.

    Article  PubMed  Google Scholar 

  189. Metelitsa AI, Fiorillo L. Recurrent Gianotti-Crosti syndrome. J Am Acad Dermatol. 2011;65:876–7.

    Article  PubMed  Google Scholar 

  190. Retrouvey M, Koch LH, Williams JV. Gianotti-Crosti syndrome following childhood vaccinations. Pediatr Dermatol. 2013;30:137–8.

    Article  PubMed  Google Scholar 

  191. Ricci G, Patrizi A, Neri I, Specchia F, Tosti G, Masi M. Gianotti-Crosti syndrome and allergic background. Acta Derm Venereol. 2003;83:202–5.

    Article  CAS  PubMed  Google Scholar 

  192. Schneider JA, Rainer Poley J, Millunchick EW, Orcutt MA, de Triquet JM. Papular acrodermatitis (Gianotti-Crosti syndrome) in a child with anicteric hepatitis B, virus subtype adw. J Pediatr. 1982;101:219–22.

    Article  CAS  PubMed  Google Scholar 

  193. Duarte AF, Cruz MJ, Baudrier T, Mota A, Azevedo F. Unilateral laterothoracic exanthem and primary Epstein-Barr virus infection. Pediatr Infect Dis J. 2009;28:549–50.

    Article  PubMed  Google Scholar 

  194. Gragasin FS, Metelitsa AI. Unilateral laterothoracic exanthem. Can Med Assoc J. 2012;184:322.

    Article  Google Scholar 

  195. Coustou D, Masquelier B, Lafon ME, Labrèze C, Roul S, Bioulac-Sage P, et al. Asymmetric periflexural exanthem of childhood: microbiologic case-control study. Pediatr Dermatol. 2000;17:169–73.

    Article  CAS  PubMed  Google Scholar 

  196. Guimerá-Martín-Neda F, Fagundo E, Rodríguez F, Cabrera R, Sánchez R, García M, et al. Asymmetric periflexural exanthem of childhood: report of two cases with parvovirus B19. J Eur Acad Dermatol Venereol. 2006;20:461–2.

    Article  PubMed  Google Scholar 

  197. McCuaig CC, Russo P, Powell J, Pedneault L, Lebel P, Marcoux D. Unilateral laterothoracic exanthem: a clinicopathologic study of 48 patients. J Am Acad Dermatol. 1996;34:979–84.

    Article  CAS  PubMed  Google Scholar 

  198. Niedermeier A, Pfützner W, Ruzicka T, Thomas P, Happle R. Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol. 2014;39:351–3.

    Article  CAS  PubMed  Google Scholar 

  199. Stalkup JR, Chilukuri S. Enterovirus infections: a review of clinical presentation, diagnosis, and treatment. Dermatol Clin. 2002;20:217–23.

    Article  PubMed  Google Scholar 

  200. Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. 1995;20:1201–6.

    Article  CAS  PubMed  Google Scholar 

  201. Rotbart HA, Webster AD. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32:228–35.

    Article  CAS  PubMed  Google Scholar 

  202. Lott JP, Liu K, Landry ML, Nix WA, Oberste MS, Bolognia J, et al. Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection. J Am Acad Dermatol. 2013;69:736–41.

    Article  PubMed  Google Scholar 

  203. Mathes EF, Oza V, Frieden IJ, Cordoro KM, Yagi S, Howard R, et al. “Eczema coxsackium” and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132:149–57.

    Article  Google Scholar 

  204. Scott LA, Stone MS. Viral exanthems. Dermatol Online J. 2003;9:4. Available at: http://escholarship.org/uc/item/3wd095bt. Accessed 1 Jul 2015.

    PubMed  Google Scholar 

  205. Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal M. 2009;14:222–7.

    Article  Google Scholar 

  206. Tindall JP, Callaway JL. Hand-foot-and-mouth disease-it’s more common than you think. Am J Dis Child. 1972;124:372–5.

    CAS  PubMed  Google Scholar 

  207. American Academy of Pediatrics. Antiviral drugs. In: Pickering LK, editor. Red book: 2012 report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p. 841–6.

    Google Scholar 

  208. Lee KC, Tschudy MM, Arcara KM. Drug doses. In: Tschudy MM, Arcara KM, editors. The Harriet Lane handbook. 19th ed. Philadelphia: Elsevier; 2012. p. 661–987.

    Chapter  Google Scholar 

  209. National Collegiate Athletic Association: Wrestling 2013–14 and 2014–15 Rules and Interpretations. Available at: http://www.ncaapublications.com/productdownloads/WR15.pdf. Accessed 20 Dec 2014.

  210. National Federation of State High School Associations Medical Release Form for Wrestler to Participated with Skin Lesion(s). Available at: http://www.nfhs.org/media/882323/wr_skin_lesion_form-clean.pdf.. Accessed 20 Dec 2014.

  211. Al Rubaie S, Breuer J, Inshasi J, Al Saady S, Fathi I. Epidermodysplasi a verruciformis with neurological manifestations. International Journal Of Dermatology [serial on the Internet]. (1998, Oct), [cited August 23, 2016]; 37(10): 766–771

    Google Scholar 

  212. Basdag H, Rainer B, Cohen B. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatric Dermatology [serial on the Internet]. (2015, May), [cited August 23, 2016]; 32(3): 353-357]

    Google Scholar 

  213. Hanna D, Hatami A, Powell J, Marcoux D, Maari C, McCuaig C, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatric Dermatology [serial on the Internet]. (2006, Nov) 2016;23(6):574–579

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA

    Jillian Rork

  2. Department of Dermatology, University of Massachusetts, 281 Lincoln Street, Worcester, MA, 01605, USA

    Kristen Corey, Heather Summe & Karen Wiss

  3. Division of Allergy and Immunology, Department of Medicine, Dermatology Program, Harvard Medical School, Boston Children’s Hospital, Boston, MA, USA

    Sophia Delano

Authors
  1. Jillian Rork
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristen Corey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heather Summe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sophia Delano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen Wiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Wiss .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, California, USA

    Joyce M.C. Teng

  2. Stanford University School of Medicine, Stanford, California, USA

    Ann L. Marqueling

  3. Pediatric Dermatology, Joe DiMaggio Children’s Hospital, Hollywood, Florida, USA

    Latanya T. Benjamin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rork, J., Corey, K., Summe, H., Delano, S., Wiss, K. (2017). Viral Diseases and Exanthems of the Skin. In: Teng, J., Marqueling, A., Benjamin, L. (eds) Therapy in Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-43630-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43630-2_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43628-9

  • Online ISBN: 978-3-319-43630-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation